The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy

<div>Correlation between the frequency of NKp46<sup>bright</sup> NK and the decrease in HBsAg levels. The association of NKp46<sup>bright</sup> NK frequency at baseline (a) and after PEG-IFN treatment for 12 weeks (b) and the decrease of HBsAg level after PEG-IFN treatment for 48 weeks.</div>

BioMed Research International

fig4

Figure 4

Figure 4: The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy 